Drugs and the cardiovascular system: The vasculature Flashcards

1
Q

identify the mechanisms regulating vascular tone and peripheral vascular resistance

A

vasoconstriction - decreased radius and flow, increased resistance
Vasodilation - increased radius and flow, decreased resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is vascular tone

A

Arteriolar smooth muscle normally displays a state of partial constriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is blood pressure calculated

A

Cardiac output x Total peripheral resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the clinical definition of hypertension and what is an important risk factor for

A

BP consistently above 140/90 mmHg

Single most important risk factor for stroke, causing about 50% of ischaemic strokes
Major risk factor for myocardial infarction (MI) + chronic kidney disease (KD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the first step in hypertension treatment

A

<55 - ACE inhibitor OR angiotensin receptor blocker (ARB)

> 55 / afro caribbean - Calcium channel blocker (CCB) or thiazide-like diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the second step in hypertension treatment

A

CCB + ACEi or ACEi + thiazide type diuretic

Afro caribbean - ARBs preferred to ACEi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the third step in hypertension treatment

A

Combination of ACEi/ ARB with CCB and thiazide-like diuretic is recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the fourth step in hypertension treatment/ treatment for resistant hypertension

A

Consider low-dose spironolactone

Consider beta-blocker or alpha blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the mechanism of action for ACEi

A

Inhibit the somatic form of angiotensin converting enzyme (ACE)
Prevent the conversion of angiotensin I to angiotensin II by ACE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the uses of ACEi

A
Hypertension
Heart failure
Post-myocardial infarction
Diabetic nephropathy 
Progressive renal insufficiency 
Patients at high risk of cardiovascular disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Give an example of an ACEi

A

Enalapril

suffix -pril is indicative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does hypertension lead to an increased CO

A

Increased TPR directly contributes to increased BP and increased venous return leads to increased cardiac contractility (via Starling’s Law) and thus CO.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does heart failure lead to oedema

A

Increased vasoconstriction increases the afterload and increases cardiac work. Increased venous return leads to long term fluid retention and congestion, leading to oedema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Give an example of a angiotensin receptor blocker (ARB)

A

Losartan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Give the mechanism of action for ARBs

A

Antagonists of type 1 (AT1) receptors for Ang II, preventing the renal and vascular actions of Ang II

AT1 found on vessels, kidney and adrenaline glands
Reduction in vasoconstriction, salt and water retention and aldosterone secretion (and thirst via SNS/CNS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the uses of ARBs

A

Hypertension

Heart failure

17
Q

What are the side effects of ACE inhibitors and ARBs

A

COUGH (ACEi - due to bradykinin accumulation as ACE usually converts it to inactive metabolites)

Hypotension
Hyperkalaemia (care with K supplements or K-sparing diuretics)
Renal failure in patients with renal artery stenosis

18
Q

Describe the excitation-contraction process of smooth muscle contraction

A
  1. Membrane depolarisation opens voltage-gated calcium (Ca2+) channels (VGCCs)
  2. Ca2+ enters & binds to calmodulin (CaM)
  3. Ca2+-CaM complex binds to & activates myosin light chain kinase (MLCK)
  4. MLCK mediated phosphorylation
  5. smooth muscle contraction
19
Q

What are the two types of calcium channels blockers and describe them

A

dihydropyridines (DHPs)
More selective for blood vessels
Also licensed for prophylaxis of angina

Non-DHPs
Rate-limiting

20
Q

Give an example of the two types of calcium channels blockers and their inotropic effects

A

Dihydropyridines (DHPs)
Amlodipine (no negative inotropy)

Non-DHPs
Verapamil (large negative inotropic effect)

21
Q

Which of the calcium channel blockers would you use to treat hypertension?

A

Dihydropyridines
inhibits Ca2+ entry into vascular smooth muscle cells
Decreased TPR and BP

22
Q

Why are alpha blockers used as anti-hypertensives

A

Blockade alpha1 receptors

Block vasoconstriction, reduce blood pressure

23
Q

What are the targets of prazosin and phentolamine

A

Alpha blockers
Prazosin targets a1 receptors
Phentolamine targets a1 and a2 receptors

24
Q

Why are ACEi and ARBs contraindicated for renal failure patients with renal artery stenosis

A

Glomerular pressure must be sufficient enough to drive GFR
ANG II controls this pressure usually. When pressure drops, ANG II is released and constricts the efferent arteriole so blood cannot leave the glomerulus effectively and GFR is restored

Patients with renal failure cannot regulate their glomerular pressure

25
Q

Why are elderly and afro Caribbean given CCBs as first line

A

Low plasma renin activity

elderly - Hypertension is usually due to atherosclerosis, RAAS desensitises

26
Q

Compare RASi to CCBs

A

CCBs reduce SBP more than RAS inhibitors
RAS inhibitors decrease heart failure
RAS inhibitors increase stroke
No difference for all-cause death

27
Q

Compare RASi to thiazides

A

Thiazides reduce SBP more than RAS inhibitors
RAS inhibitors increase heart failure and stroke
No difference for all-cause death

28
Q

Compare RASi to beta blockers

A

No difference in SBP reduction
RAS inhibitors reduce CV events and stroke
No difference for all-cause death